Exome Asset Management »

Ultragenyx Pharmaceutical In shares owned by Exome Asset Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical In shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Ultragenyx Pharmaceutical In

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical In held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical In by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $810k 35k 23.00

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Guardant Health (GH)
Ionis Pharmaceuticals (IONS)
Eli Lilly & Co. (LLY)
Cytokinetics Com New (CYTK)
Wave Life Sciences SHS (WVE)
Vera Therapeutics Cl A (VERA)
Bridgebio Pharma (BBIO)
Anthem (ELV)
Astrazeneca Sponsored Adr
Jazz Pharmaceuticals Shs Usd (JAZZ)
Natera (NTRA)
Immunovant (IMVT)
Universal Hlth Svcs CL B (UHS)

View all positions for Exome Asset Management

Top funds holding Ultragenyx Pharmaceutical In

Group One Trading
Exome Asset Management
IMC-Chicago
Jpmorgan Chase & Co

View all funds holding Ultragenyx Pharmaceutical In